CDKN1B and ovarian carcinoma: Previous investigations demonstrated that the downregulation of p27Kip1 protein is frequently observed in human cancers, including breast, lung, prostate, gastric, skin, colon, and ovarian cancer, and is usually correlated with poor clinical outcome [15].